Immediate urinary tract management
› Clot retention pathway
› Three way catheter placement
› Large bore catheter
› 22 to 24 Fr preferred for clot evacuation
› If urethral trauma concern, urology before catheterization
› Retrograde urethrogram pathway
› Manual irrigation
› Sterile saline irrigation until return clears of clots
› If inability to clear, urgent urology for cystoscopic evacuation
› Continuous bladder irrigation
› Initiate CBI after large clots cleared
› Titrate irrigation rate to light pink effluent
› Transfusion
› Packed RBC transfusion
› If symptomatic anemia
› Chest pain
› Dyspnea
› Syncope
› If ongoing brisk bleeding with instability
› Transfuse without waiting for labs
› Platelets
› If severe thrombocytopenia with active bleeding
› If platelet dysfunction with life threatening bleeding
› Hemostatic adjuncts
› Intravesical agents
› Alum irrigation
› Urology guided use for refractory bladder bleeding
› Intravesical aminocaproic acid
› Urology guided use for refractory bleeding
› Systemic antifibrinolytics
› Tranexamic acid IV
› Consider only with specialist input for severe refractory hematuria
› Avoid if active upper tract bleeding with obstruction risk concern
› Suspected cystitis
› Antibiotics per local resistance patterns
› Tailor to culture results
› Symptom control
› Phenazopyridine short course if appropriate renal function
› Suspected pyelonephritis or urosepsis
› Broad spectrum IV antibiotics
› Cover gram negatives
› Add enterococcus coverage when risk factors present
› Source control
› If obstructed infected system, emergent decompression
Anticoagulant and antiplatelet related bleeding
› Warfarin associated major bleeding
› Vitamin K IV
› 10 mg IV for life threatening bleeding
› Four factor PCC
› Weight based dosing per INR category
› Repeat INR after reversal
› Dabigatran associated major bleeding
› Idarucizumab
› 5 g IV total dose
› Factor Xa inhibitor associated major bleeding
› Four factor PCC
› 50 units/kg IV when life threatening bleeding and andexanet unavailable or not used
› Andexanet alfa
› Use per institutional protocol and indication
› Antiplatelet associated major bleeding
› Platelet transfusion
› Consider for life threatening bleeding with recent antiplatelet ingestion
› Desmopressin
› 0.3 mcg/kg IV for platelet dysfunction support in selected cases
› Renal colic pattern
› NSAID therapy
› Ketorolac IV
› 15 mg IV
› Avoid in severe AKI
› Opioid rescue
› If NSAID contraindicated or inadequate
› Bladder spasm with catheter
› Anticholinergic therapy
› Oxybutynin PO
› 5 mg PO
› Caution in older adults delirium risk
Show 49 more ▾